University of Pennsylvania Medical Center
7th Floor Rhoads Pavillion
3400 Spruce Street
Philadelphia, PA 19104
Direct phone: (215) 662-3800
http://www.oncolink.com
|
Program Description: |
Transplants performed from related and unrelated donors using ablative and non-myeloablative conditioning, with marrow, blood stem cells and cord blood. Standard and investigational therapies available. Research focuses on improving safety, minimizing GVHD and enhancing graft-versus-tumor effect. |
Contact Information: |
If you have transplant-related questions, please contact Joanne Hinkle, transplant center coordinator, at (215) 614-0111 or by e-mail at joanne.hinkle@uphs.upenn.edu. |
Program Type: |
Adult |
Attending Physicians:
(Medical Doctors) |
Adult - Noelle Frey, Elizabeth Hexner, Rebecca Hirsh, Alison Loren, Selina Luger, James Mangan, Sunita Nasta, Alexander Perl, David Porter, Ran Reshef, Stephen Schuster, Edward Stadtmauer, Jakub Svoboda, Donal Tsai, Dan Vogl, Brendan Weiss |
Transplants Performed: |
Marrow/PBSC, single cord, and double cord |
Cord blood transplants performed on: |
Adult only |
Explain Transplant Center HLA Match Requirements
Estimated Search & Transplant Costs
The costs for a transplant vary greatly from center to center and depend
on factors such as health insurance, disease type and disease stage of
the patient, as well as center-specific billing policies. Examples of
costs in the search and transplant include:
- The amount and geographic location of donors tested
- Testing needed to confirm a match
- Processing and collecting of tissue-typing samples
- Donor workup testing needed
- Getting the marrow, PBSC or cord blood unit for transplant
For the best understanding of costs of transplant and follow-up for a
specific transplant center, contact the center's Financial Representative.
Explain Transplant Costs at Different Centers
Financial Services:
Financial services at this center could include:
- Health insurance information
- Financial assistance
- Patient-related resources
|
Resources for financial information
If you have questions about costs and financial services at this
transplant center, you can contact the center's financial
representative, Joanne Hinkle by e-mail at joanne.hinkle@uphs.upenn.edu or by phone at (215) 614-0111.
Many organizations exist to help patients with lodging, transportation and
other transplant-related expenses. Visit the National Marrow Donor Program's
Patient Organizations database
for more information. Financial assistance resources are also listed
on this Web site.
|
Transplant Experience
This center has been performing allogeneic transplants since 1996 and has been an NMDP transplant center since April 1999.
Transplants Reported
(From Jan. 2010 to Dec. 2011
as reported by the centers)
|
Unrelated or Related Donor |
Auto-
logous
(PBSC or marrow) |
Total(by transplant type) |
Total Non-
Myeloablative transplants* |
Marrow |
PBSC |
Cord
Blood |
| Unrelated Donor - Adult |
24 |
64 |
4 |
--- |
92 |
49 |
| Unrelated Donor - Pediatric |
0 |
0 |
0 |
--- |
0 |
0 |
| Related Donor - Adult |
5 |
60 |
0 |
--- |
65 |
29 |
| Related Donor - Pediatric |
0 |
0 |
0 |
--- |
0 |
0 |
| Autologous - Adult |
--- |
--- |
--- |
283 |
283 |
--- |
| Autologous - Pediatric |
--- |
--- |
--- |
0 |
0 |
--- |
| Total (by cell source) |
29 |
124 |
4 |
283 |
440 |
78 |
*The total Non-Myeloablative transplants column shows a subset of the total number of transplants by type.
To locate centers that perform cord blood transplants, use the search tool on this site.
The NMDP also has Transplants by Disease Charts available showing the number of NMDP coordinated transplants by disease category at each U.S. transplant center.
Explain Transplant Experience
Center-Specific Analysis
This analysis includes ONLY patients who received their FIRST ALLOGENEIC* transplant
between January 1, 2008 and December 31, 2010 using unrelated or related donors, and
who had at least a 100-day follow-up.
- This center reported survival status data for 196 patients.
- The actual one-year survival of these patients is 54%.
- Based on a national average for patients like those transplanted at this center, 95% of the time the one-year survival is expected to be between 58% and 71% for patients at this center.
- This center's actual results are below the expected range for this center.
*Allogeneic means using cells from a person other than the patient.
For help with understanding these statistics, please see Understanding Transplant Outcomes (PDF).
Survival by Patient's Age, Disease Type and Stage
If you do not find your disease in the statistics below, it may be combined with other similar diseases in a category. Please refer to our broad disease categories page for more information.
Further information about this center, including the number and type of
transplants performed in each of the last three years, and the support groups
offered, may be found in the BMT InfoNet Transplant Center Directory:
http://www.bmtinfonet.org/transplantcenters.
BMT InfoNet (Blood & Marrow Transplant Information Network) is a
nonprofit organization that provides information and emotional support
to transplant patients and their families.
Please take a
brief
survey to share your feedback on the transplant center informational listings.